Midgard Science

Labs / ADME, DMPK & toxicology

Helix Biopharma

Toronto, ON, Canada · helixbiopharma.com

On your own

Free. Their own form.

Contact Helix Biopharma directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Helix Biopharma is a clinical-stage oncology company developing novel therapies for difficult-to-treat cancers. It focuses on CEACAM6-targeted programs, including therapies for advanced solid tumors, non-small cell lung cancer, and leukemia relapse after allogeneic stem cell transplantation. The company is based in Vancouver, British Columbia, Canada.

They take quote requests by email.

What they offer

  • L-DOS47 development

    Develops L-DOS47, a CEACAM6-targeted antibody-enzyme conjugate designed to counter tumor acidosis and improve responses to immunotherapy in advanced NSCLC.

  • LEUMUNA™ development

    Develops LEUMUNA™, an oral immune checkpoint modulator for leukemia relapse following allogeneic stem cell transplantation.

  • GEMCEDA™ development

    Develops GEMCEDA™, an oral gemcitabine-based therapy for advanced solid tumors.

  • CEACAM6-targeted pipeline development

    Advances next-generation CEACAM6-targeted programs, including antibody-drug conjugates and radioligand therapeutics.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Recombinant protein
Therapeutic areas
oncology, solid tumors, non-small cell lung cancer, leukemia
Sites
Vancouver, Canada
Address
789 West Pender Street, Suite 480, Vancouver, British Columbia, V6C 1H2

Public records

Ownership
HELIX BIOPHARMA CORP. · CA GLEIF

Similar labs. Venenum Biodesign, Aurigene Pharmaceutical Services, AxisPharm, Bio Synthesis

Found in a contract services directory. Listing built from helixbiopharma.com. Work here? Claim this listing.

Helix Biopharma · Midgard Science